Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 13 / 2025
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Copenhagen, Denmark, May 27, 2025 – Zealand Pharma A/S ('the Company' or 'Zealand Pharma') (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand Pharma's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions.
Please see the attached file(s).
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ('Zealand') is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the United States. For more information about Zealand's business and activities, please visit www.zealandpharma.com.
Contacts
Adam Lange (Investors)
Vice President, Investor Relations
Zealand Pharma
Email: [email protected]
Neshat Ahmadi (Investors)
Investor Relations Manager
Zealand Pharma
Email: [email protected]
Anna Krassowska, PhD (Investors and Media)
Vice President, Investor Relations & Corporate Communications
Zealand Pharma
Email: [email protected]
Attachment
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
30 minutes ago
- Business Upturn
The Week That Was, June 1 to June 7, 2025: RBI cuts repo rate by 50 bps, BEL secures Rs 2,323 crore order, Musk-Trump feud escalates, Coal India signs MoU for rail infra
In a week marked by major policy announcements, strategic deals, and sectoral movements, the Reserve Bank of India (RBI) took centre stage by delivering a surprise 50 basis points rate cut on June 6, bringing the repo rate down to 5.50%. This marked the third straight reduction in 2025, totaling a 100 bps cut to support growth amid global uncertainty. RBI Governor Sanjay Malhotra signaled continued comfort with inflation, lowering the CPI forecast for FY26 to 3.7% from 4% and retaining GDP growth expectations at 6.5% for the year. In a liquidity-boosting move, the central bank also slashed the Cash Reserve Ratio (CRR) by 100 bps to 3%, to be implemented in four tranches between September and November, unlocking ₹2.5 lakh crore into the banking system. Further, the RBI raised the loan-to-value (LTV) cap for small gold loans up to ₹2.5 lakh from 75% to 85%, a move that significantly benefited gold financing stocks. Among corporate highlights, the RBI gave a clean regulatory signal to IndusInd Bank, affirming its accounting standards, which pushed its shares up by over 5%. Infrastructure firm Ashoka Buildcon, however, faced a setback as its ₹1,673 crore project under CIDCO's NAINA initiative encountered execution hurdles. In the energy and defense sectors, Coal India signed a key MoU with Indian Port Rail & Ropeway Corporation to develop rail infrastructure, while GRSE expanded its global presence by signing MoUs in Sweden and Denmark for cruise vessel and marine propulsion collaboration. Similarly, Bharat Electronics Limited (BEL) secured orders worth ₹2,323 crore from MDL and GRSE, strengthening its defense manufacturing portfolio. JSW Energy exited Beempow Energy for ₹302.66 crore, completing a strategic realignment, and RailTel bagged a ₹274 crore ITMS project in Maharashtra's Vidarbha Circle, aimed at enhancing road safety across blackspots and accident-prone zones. Meanwhile, KEC International won ₹2,211 crore worth of new orders across international T&D, pipelines, and cable supply businesses, reinforcing its infrastructure footprint in the Middle East and Africa. In the equity markets, Gravita India surged 4% on expectations of a government-backed critical mineral recycling scheme. Tata Investment gained 8% on reports of Tata Capital's impending IPO, while shares of ICICI Lombard and Go Digit also moved higher as the government weighed a 25% hike in third-party motor insurance premiums. Lastly, global cues remained mixed. While Asian markets were relatively steady, U.S. indices such as Nasdaq and S&P 500 dipped amid fresh tariff tensions and a high-profile online spat between Elon Musk and Donald Trump—an episode that dented Tesla's valuation and contributed to market volatility. Overall, the week was dominated by aggressive monetary easing, strong defense-industry momentum, and corporate actions that may shape the economic narrative for the weeks ahead. Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Yahoo
33 minutes ago
- Yahoo
Prediction: in 12 months the dirt-cheap Shell share price could turn £10,000 into…
The Shell (LSE SHEL) share price looks cheap right now, with a price-to-earnings ratio of just 8.95. That's well below the average FTSE 100 P/E of 15 times. There's a reason for that, of course. Shell shares have fallen with the oil price, slumping almost 10% in 12 months. They're still up 67% over five years though. That's less than half the drop suffered by FTSE 100 rival BP. Shell seems to have a better idea how to navigate the push to net zero, but with the oil price hovering around $65 a barrel, it's still struggling. It's far from a done deal that Shell can bounce back from today's lows and make investors rich all over again. There is little sign the oil price is about to recover. With OPEC+ increasing production, it could fall further, especially as China struggles and Donald Trump brings volatility. Then there's the push towards net zero, which could go either way. Theoretically, building a new line of renewable energy will threaten fossil fuel behemoths, but we need them to help us push through the transition. This is particularly true given exponentially rising energy demand, thanks to AI and the rest. Shell's first-quarter results, published on 2 May, showed adjusted earnings of $5.6bn. That's a big drop from $7.73bn a year earlier but ahead of analyst expectations of $4.96bn. The company also announced another $3.5bn quarterly share buyback programme, marking the 14th consecutive quarter of at least $3bn in buybacks. Cash flow from operations came in at $9.3bn, slightly below consensus expectations of $9.6bn. So what about that dividend? A trailing yield of 4.4% is okay, but not exactly to die for. It's expected to creep up in 2026, but only to 4.49%. Shell isn't the dividend superstar it once was. Over the last 15 years, I would have expected shareholder payouts to compound at a decent clip. Instead, it's fallen by an average of 2.88% a year. The board didn't just slash its full-year dividend from 188 US cents in 2019 to 65.3 cents during the 2020 pandemic. It rebased it. While payouts have climbed at a decent clip since, they started from that lower level. In 2024, the total dividend was 139 US cents. That's at levels last seen in 2007. The 19 analysts serving up one-year share price forecasts have produced a median target of around 3,027p. If correct, that's a handsome increase of around 21.5% from today. Combined with that yield, this would give investors a total return of 26%. Based on that, if somebody invested £10,000 in the stock today, it would grow to £12,600 in a year. Obviously, nobody can predict the future like that. I use it only as a guide to market thinking. Here's another. Of the 32 analysts giving one-year stock ratings, an impressive 23 name Shell a Strong Buy. Four say Hold and five say Sell. Shell continues to face risks, as the oil price slows, net zero spreads confusion, and the global economy struggles. It may look cheap, but there's no guarantee its shares will suddenly close the valuation gap. But for those wanting exposure to energy, today's low valuation does make Shell worth considering. More so than BP, in my book. The post Prediction: in 12 months the dirt-cheap Shell share price could turn £10,000 into… appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Harvey Jones has positions in Bp P.l.c. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
Yahoo
an hour ago
- Yahoo
3 cheap, near-penny shares to consider buying in June
The Premier Miton Group (LSE: PMI) share price is down 40% in five years and is well below the 100p level for penny shares. But a modest 2025 rise has pushed the market-cap above the usual £100m limit, but only just. It's an investment management company. And faced with high interest rates and shaky economies, investors have been favouring savings accounts, gold, and safer things rather than stocks and funds. With just £10.4bn in assets under management, this is a sector tiddler. And that has to raise the risk. But the stock was boosted by first-half results. Profit before tax reached £5.4m, and the company held £31.2m cash with no debt. Also by 22 May, 71% of funds were outperforming their sectors. There's a forecast 9% dividend yield, which could be at risk as economic pressures continue. This isn't the safest penny stock out there. But I'd say the recovery potential makes it worth considering. Avacta Group's (LSE: AVCT) a biotech company specialising in diagnostics and therapeutics. The share price had a couple of good Covid years as the company developed test kits. But that's long since faded and we've seen a five-year fall of more than 75%. At around 34p, at the time of writing, it's a penny share on that score. And I don't think the market-cap's too far out at £135m. The main problem's a lack of profit. With full-year results delivered on 6 June, CEO Christina Coughlin said the company's oncology technology 'has the potential to treat up to 90% of solid tumors by repurposing a range of effective oncology drugs to significantly reduce toxicity and side effects.' But it's only just moving towards the Phase 1 trial stage. Results showed a loss from continuing operations of £29m, with cash and equivalents of £12.9m on the books at 31 December 2024. The likelihood of needing more cash seems high. So it's a very risky one. But the rewards could be significant. Worth a closer look, I'd say. I like housebuilders, but AIM-listed Springfield Properties (LSE: SPR) had escaped my eye. We're looking at a market-cap of £112m, with the share price a few pennies below the magic pound threshold. It was up over 170p in mid-2021. The forecast price-to-earnings (P/E) ratio's only 7.5. Revenue fell 13% in the first half, though some blame was directed at Scottish government delays in affordable housing contracts. Scotland? Oh yes, that's were this builder lays its bricks. The report showed higher profits, with a gross margin rising to 17.7% from 14.7%. The company said it has a 'large, high quality land bank'. And it added that the 'long-term fundamentals of the Scottish housing market remain strong'. Net bank debt fell 33%. I'd say the smaller focus means more risk than nationwide builders. But if we're seeing the signs of a new bull run, as I suspect, it could be another cheap stock to consider now. The post 3 cheap, near-penny shares to consider buying in June appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
